Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aerpio Therapeutics Inc.
DescriptionHypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha) stabilizer
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today